Just Closed: Redmile Group raises $30m

View the latest closings

Redmile Group has raised $30 million for its Redmile Biopharma Investments I, according to a SEC filing. The San Francisco-headquartered firm began fundraising in 2015 with a $150 million target.

The fund will target venture capital opportunities in healthcare sectors in North America.